Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis

Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring hospital admission. Aim This study was aimed to evaluate the epidemiology of VTE in hospitalized intensive care unit...

Full description

Bibliographic Details
Main Authors:	Eman M. Mansory, Suthan Srigunapalan, Alejandro Lazo-Langner
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2021-07-01
Series:	TH Open
Subjects:	venous thromboembolism anticoagulation covid-19
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1730967

Similar Items

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
by: Francesco Poletto, et al.
Published: (2022-03-01)

Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
by: Camille Simard, et al.
Published: (2022-08-01)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
by: Faizan Khan, et al.
Published: (2019-10-01)

Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice
by: I. V. Zotova, et al.
Published: (2020-09-01)

Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients
by: Lai Heng Lee, et al.
Published: (2022-10-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
by: U Vasudeva Rao, et al.
Published: (2021-01-01)

Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)

Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis
by: Dae Yong Park, et al.
Published: (2023-02-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

Incidence of Venous Thromboembolism in Hospitalized Coronavirus Disease 2019 Patients: A Systematic Review and Meta-Analysis
by: Chi Zhang, et al.
Published: (2020-08-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
by: Gualtiero Palareti
Published: (2018-09-01)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
by: Viktoria Muster, et al.
Published: (2021-06-01)

FEATURES OF PROPHYLAXIS OF POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ONCOLOGIC PATIENTS
by: I. I. Katelnitskyy, et al.
Published: (2014-12-01)

Risk assessment for recurrent venous thromboembolism in patients with cancer
by: Cornelia Englisch, et al.
Published: (2021-12-01)

Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data
by: Valdis Ģībietis, et al.
Published: (2019-08-01)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
by: Elizabeth Joyce, et al.
Published: (2022-11-01)

Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
by: Brittany Scarpato, et al.
Published: (2022-03-01)

Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension
by: Yong-Jian Zhu, et al.
Published: (2021-05-01)

Chemical prophylaxis and venous thromboembolism following elective spinal surgery: A systematic review and meta-analysis
by: Roman Rahmani, DO, et al.
Published: (2024-03-01)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
by: Proietti M, et al.
Published: (2016-02-01)

Oral anticoagulants: Optimizing venous thromboembolism management
by: Fahad A S. Aleidan
Published: (2019-01-01)

OUTPATIENT TREATMENT OF PATIENTS WITH CANCER AND VENOUS THROMBOEMBOLISM
by: Urška Cvajnar, et al.
Published: (2015-09-01)

Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
by: Victoria Speed, et al.
Published: (2021-12-01)

Clinical and Safety Outcomes Associated with Extended Treatment of Venous Thromboembolism: A Network Meta-Analysis
by: Zhiqiang Liu, et al.
Published: (2022-11-01)

A survey of the clinical management of pediatric patients with asymptomatic central venous catheter-associated venous thromboembolism in Saudi Arabia
by: Bader Allahyani, et al.
Published: (2021-01-01)

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-08-01)

Bleeding and venous thromboembolism events in cancer patients taking direct oral anticoagulants vs. low molecular weight heparin
by: Frank A. Lattuca, et al.
Published: (2023-03-01)

Platelet count and risk of major bleeding in venous thromboembolism
by: Håkon S. Johnsen, et al.
Published: (2021-05-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01)

Direct factor Xa inhibitor in the prevention of thromboembolism
by: Viktor Meretskyi, et al.
Published: (2019-01-01)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)

Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis
by: Xinwang Chen, et al.
Published: (2024-04-01)

The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis
by: Corinne Frere, et al.
Published: (2022-06-01)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)

Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
by: Han Young Lee, et al.
Published: (2021-12-01)

The recent clinical trials on use of the novel direct oral anticoagulants in patients with venous thromboembolism: a review
by: Gualtiero Palareti
Published: (2014-10-01)

Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-12-01)